🚀 VC round data is live in beta, check it out!
LifeMD Valuation Multiples
Discover revenue and EBITDA valuation multiples for LifeMD and similar public comparables like JETEMA Co., Midsona, Leifheit, Acme United and more.
LifeMD Overview
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Founded
1994
HQ
Employees
336
Website
Financials (LTM)
EV
$163M
LifeMD Financials
LifeMD reported last 12-month revenue of $203M and EBITDA of $15M.
In the same LTM period, LifeMD generated $181M in gross profit, $15M in EBITDA, and $6M in net income.
Revenue (LTM)
LifeMD P&L
In the most recent fiscal year, LifeMD reported revenue of $194M and EBITDA of $15M.
LifeMD expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $203M | XXX | $194M | XXX | XXX | XXX |
| Gross Profit | $181M | XXX | $166M | XXX | XXX | XXX |
| Gross Margin | 89% | XXX | 86% | XXX | XXX | XXX |
| EBITDA | $15M | XXX | $15M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | (2%) | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | $6M | XXX | $14M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
LifeMD Stock Performance
LifeMD has current market cap of $194M, and enterprise value of $163M.
Market Cap Evolution
LifeMD's stock price is $4.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $163M | $194M | 3.8% | XXX | XXX | XXX | $0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLifeMD Valuation Multiples
LifeMD trades at 0.8x EV/Revenue multiple, and 11.1x EV/EBITDA.
EV / Revenue (LTM)
LifeMD Financial Valuation Multiples
As of April 18, 2026, LifeMD has market cap of $194M and EV of $163M.
Equity research analysts estimate LifeMD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LifeMD has a P/E ratio of 34.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $194M | XXX | $194M | XXX | XXX | XXX |
| EV (current) | $163M | XXX | $163M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.1x | XXX | 10.7x | XXX | XXX | XXX |
| EV/EBIT | (42.8x) | XXX | (56.5x) | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
| P/E | 34.8x | XXX | 13.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (131.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified LifeMD Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
LifeMD Margins & Growth Rates
LifeMD's revenue in the last 12 month grew by 16%.
LifeMD's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.5M for the same period.
LifeMD's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LifeMD's rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
LifeMD Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | (12%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 50% | XXX | 52% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 31% | XXX | 33% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 90% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
LifeMD Public Comps
See public comps and valuation multiples for other Telemedicine & Virtual Care and Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| LifeMD | XXX | XXX | XXX | XXX | XXX | XXX |
| JETEMA Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Midsona | XXX | XXX | XXX | XXX | XXX | XXX |
| Leifheit | XXX | XXX | XXX | XXX | XXX | XXX |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| MTI Ltd. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LifeMD M&A Activity
LifeMD acquired XXX companies to date.
Last acquisition by LifeMD was on XXXXXXXX, XXXXX. LifeMD acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by LifeMD
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLifeMD Investment Activity
LifeMD invested in XXX companies to date.
LifeMD made its latest investment on XXXXXXXX, XXXXX. LifeMD invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by LifeMD
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout LifeMD
| When was LifeMD founded? | LifeMD was founded in 1994. |
| Where is LifeMD headquartered? | LifeMD is headquartered in United States. |
| How many employees does LifeMD have? | As of today, LifeMD has over 336 employees. |
| Who is the CEO of LifeMD? | LifeMD's CEO is Justin Schreiber. |
| Is LifeMD publicly listed? | Yes, LifeMD is a public company listed on Nasdaq. |
| What is the stock symbol of LifeMD? | LifeMD trades under LFMD ticker. |
| When did LifeMD go public? | LifeMD went public in 1995. |
| Who are competitors of LifeMD? | LifeMD main competitors are JETEMA Co., Midsona, Leifheit, Acme United. |
| What is the current market cap of LifeMD? | LifeMD's current market cap is $194M. |
| What is the current revenue of LifeMD? | LifeMD's last 12 months revenue is $203M. |
| What is the current revenue growth of LifeMD? | LifeMD revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of LifeMD? | Current revenue multiple of LifeMD is 0.8x. |
| Is LifeMD profitable? | Yes, LifeMD is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LifeMD? | LifeMD's last 12 months EBITDA is $15M. |
| What is LifeMD's EBITDA margin? | LifeMD's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of LifeMD? | Current EBITDA multiple of LifeMD is 11.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.